FDA clears ImmersiveTouch augmented reality surgical system
July 10, 2024
ImmersiveTouch announced today that it received FDA 510(k) clearance for its ImmersiveAR augmented reality technology platform.
ImmersiveTouch announced today that it received FDA 510(k) clearance for its ImmersiveAR augmented reality technology platform.
CAMP HILL, Pa.–(BUSINESS WIRE)–Forma Medical Inc., a leading innovator in medical device technologies, is thrilled to announce the FDA 510(k) clearance for its groundbreaking OptimalMTP® Plating System. This regulatory milestone marks a significant leap forward in MIS (Minimally Invasive Surgery), ushering in a new era of precision and efficiency dedicated to foot and ankle surgery, one of the fastest growing segments in the medical device space.
To bring light’s benefits to these harder-to-access cancers, engineers and scientists at the University of Notre Dame have devised a wireless LED device that can be implanted. This device, when combined with a light-sensitive dye, not only destroys cancer cells, but also mobilizes the immune system’s cancer-targeting response.
Roche has announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. This significant milestone paves the way for the solution to be made available to people living with type 1 and type 2 diabetes over the age of 18 on flexible insulin therapy.
Orthofix (Nasdaq: OFIX) today announced it received FDA 510(k) clearance for the Fitbone Transport and Lengthening System and reported the first implant of the device.
Cordis announced today that the FDA granted premarket approval (PMA) for its Mynx Control venous vascular closure device (VCD).
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a band-aid or plaster that measures body biomarkers that can indicate health or disease through sweat, paving the way for a new non-invasive and effective way for patients to monitor their health.
Pulse Biosciences (Nasdaq:PLSE) announced today that the FDA granted breakthrough device designation for its pulsed field ablation system. Shares of PLSE rose more than 20% in mid-morning trading on the back of this announcement.
Researchers at University of Tsukuba have pioneered a state-of-the-art wearable device capable of precisely and continuously measuring trace perspiration amounts. This innovative device is adept at monitoring perspiration levels during not only physical activity but also rest. Its potential applications extend beyond monitoring dehydration caused by exercise or heat exposure, encompassing broader domains such as daily health management and disease detection.
The Vercise Neural Navigator 5 with STIMVIEW XT technology is designed to streamline procedures for people living with neurological conditions according to the company.